Intermittent dietary restriction. Alternative treatment in type 2 diabetic patients

Authors

Abstract

Introduction: Type 2 diabetes mellitus is a multifactorial disease. Maintaining its control is essential. Intermittent dietary restriction can be an alternative, with beneficial results.
Objective: To describe the effect of intermittent dietary restriction in adult patients with type 2 diabetes mellitus.
Method: A quasi-experimental before-and-after study was conducted in Clinic 17-19 of the "Chiqui Gómez" Polyclinic between 2019 and 2022. The study population (96) consisted of all registered adult patients with type 2 diabetes mellitus. Thirty-two participants were selected by non-probability sampling based on criteria. Their basal metabolic rate was calculated, they were instructed to use intermittent dietary restriction, and its effect was observed.
Results: 53.3% of the sample were women and patients aged 50 years and older; 43.8% reported high blood pressure as a personal medical history, and 68.8% reported a diagnosis of hypertension more than five years earlier. Forty-three percent (43.7%) were using insulin. The unacceptable nutritional status before dietary restriction was 62.5% and 40.62% afterward, and blood glucose levels, which was high in 87.5%, decreased to 56.3% after a few months. After the alternative, the percentage of those using prescription medications increased from 71.9% to 93.8%, and 84.4% were treated with two or fewer medications.
Conclusions: The effect of intermittent dietary restriction established with the personalized dietary regimen based on basal metabolic rate as a therapeutic alternative showed changes in nutritional status, blood glucose levels, and medication use.

Downloads

Download data is not yet available.

Author Biographies

Tania Rivera Pérez, University of Medical Sciences of Villa Clara

Especialista de I Grado en Medicina General Integral. Master en Atención Primaria. Profesor Asistente.

Tamara Guevara de León, Dirección de Posgrado. Vicerrectorado Académico. Universidad de Ciencias Médicas de Villa Clara

Especialista de II Grados en Medicina General Integral y Gerontología y Geriatría. Master en Longevidad Satisfactoria. Profesora auxiliar. Investigador agregado

Lázara Méndez Gálvez, Faculty of Medicine. University of Medical Sciences of Villa Clara

Especialista de II Grado en Medicina General Integral. Master en Atención Integral al niño. Profesor Auxiliar. Investigador Agregado. Departamento de MGI.

Amanda González Rodríguez, 20th Anniversary Polyclinic. Santa Clara

Especialista de I Grado en Medicina General Integral. Profesor Instructor

Ildiko Garrido Bosze, Academic Vice-Rectorate. Villa Clara University of Medical Sciences

Especialista de I Grado en Medicina General Integral. Profesor Asistente. Dirección de Posgrado

Damarys Martínez Garcia, Psychiatric Hospital. Saint Clare

First-degree specialist in comprehensive general medicine and psychiatry. Assistant professor

References

1. Sapra A; Bhandari P. Diabetes [Internet]. Bethesda: StatPearls Publishing LLC; 2023 [citado 18/01/2024]. Disonible en: https://www-ncbi-nlm-nih-gov.translate.goog/books/NBK551501/?_x_tr_sl=en&_x_tr_tl=es&_x_tr_hl=es&_x_tr_pto=tc

2. International Diabetes Federation. IDF Diabetes Atlas. 10th ed. Brussels: IDF; 2021 [citado 18/01/2024]. Disponible en: https://diabetesatlas.org/resources/previous-editions/#

3. Parker ED, Lin J, Mahoney T, Ume N, Yang G, Gabbay RA, et al. Economic Costs of Diabetes in the U.S. in 2022. Diabetes Care [Internet]. 2023 [citado 18/01/2024]]. Disponible en: https://pubmed.ncbi.nlm.nih.gov/37909353/

https://doi.org/10.2337/dci23-0085

4. Deng Y, Li N, Wu Y, Wang M, Yang S, Zheng Y. Global, Regional, and National Burden of Diabetes-Related Chronic Kidney Disease From 1990 to 2019. Front Endocrinol [Internet]. 2021 [citado 18/01/2024]; 12:[aprox. 2p.]. Disponible en: https://pubmed.ncbi.nlm.nih.gov/34276558/

https://doi.org/10.3389/fendo.2021.672350

5. Marx N, Federici M, Schütt K, Müller-Wieland D, Ajjan RA, Antunes MJ. 2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes. Eur Heart J [Internet]. 2023 [citado 18/01/2024]. Disponible en: https://www.escardio.org/Guidelines/Clinical-Practice-Guidelines/CVD-and-Diabetes-Guidelines

https://doi.org/10.1093/eurheartj/ehad192

6. Patikorn C, Saidoung P, Pham T, Phisalprapa P, Lee YY, Varady KA, et al. Effects of ketogenic diet on health outcomes: an umbrella review of meta-analyses of randomized clinical trials. BMC Med [Internet]. 2023 [citado 18/01/2024]; 196:[aprox. 2p.]. Disponible en: https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-023-02874-y

https://doi.org/10.1186/s12916-023-02874-y

7. Pintado Ruiz AF, Mancheno Romero AE, García Ramón NM, Arévalos Lomas EM, Barrezueta Herrera MF. Ayuno Intermitente y la Prevención De Enfermedades Metabólicas. Revisión de la Literatura. Ciencia Latina: Revista Multidisciplinar [Internet]. 2024 [citado 18/01/2024]; 2(8): [aprox. 3p.]. Disponible en: https://dialnet.unirioja.es/servlet/articulo?codigo=9481281

8. Denner J. Cómo funciona el ayuno intermitente y cuáles son sus beneficios. [Internet]. 2021 [citado 18/01/2024]. Disponible en: https://www.google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=&cad=rja&uact=8&ved=2ahUKEwiEjvCQsuP0AhUpSjABHfmUBKUQFnoECBwQAQ&url=https%3A%2F%2Fdialnet.unirioja.es%2Fdescarga%2Farticulo%2F3974417.pdf&usg=AOvVaw0-ixdrhI37ZpEnJgVlemZP

Espinosa E, Rubio A, Camacho A. Beneficios del ayuno intermitente en la

prevención de enfermedades. Rev Nutri Hosp [Internet]. 2024 [citado 18/01/2024]; 2(XVII): [aprox. 2p.]. Disponible en: https://aasmst.es/wp-content/uploads/2024/08/AVANCES-2_2024.pdf

https://doi.org/10.20960/nh.04790

9. Almudéver-Campo L, Kovalkova K. Efectos del ayuno intermitente en pacientes con Diabetes Mellitus tipo 2. Nutr Clin Diet Hosp [Internet]. 2022 [citado 18/01/2024]; 42(1):[aprox.3p.]. Disponible en: https://revista.nutricion.org/index.php/ncdh/article/view/204

https://doi.org/10.12873/421almudever

10. Paredes Rodríguez RS, Mantilla Reyes GD, Silador Utrera RR, Bascó Fuentes EL, Bejarano Lizano BO. El ayuno intermitente en el tratamiento de la diabetes mellitus tipo 2. Mediciencias UTA [Internet]. 2022 [citado 18/01/2024]; 6(4): [aprox. 2p.]. Disponible en: https://revistas.uta.edu.ec/erevista/index.php/medi/article/view/1837

https://doi.org/10.31243/mdc.uta.v6i4.1837.2022

11. Mifflin MD, St Jeor ST, Hill LA, Scott BJ, Daugherty SA, Koh YO. A new predictive equation for resting energy expenditure in healthy individuals. Am J Clin Nutr [Internet]. 1990 [citado 18/01/2024]; 51(2): [aprox. 3p.].Disponible en: https://revistas.uta.edu.ec/erevista/index.php/medi/article/view/1837

https://doi.org/10.31243/mdc.uta.v6i4.1837.2022

12. International Diabetes Federation. World Congress of Diabetes [Internet]. India: IDF; 2025 [citado 18/01/2024]. Disponible en: https://idf.org/events/idf-events/world-congress-of-diabetes/

13. Bjornstad P, Hughan K, Kelsey MM, Shah AS, Lynch J, Nehus E, et al. Effect of surgical versus medical therapy on diabetic kidney disease over 5 years in severely obese adolescents with type 2 diabetes. Diabetes Care [Internet]. 2020 [citado 18/01/2024]; 43(1):[aprox. 2p.]. Disponible en: https://pubmed.ncbi.nlm.nih.gov/31685489/

https://doi.org/10.2337/dc19-0708

14. Visseren FLJ, MacH F, Smulders YM, Carballo D, Koskinas KC, Bäck M, et al. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J [Internet]. 2021 [citado 18/01/2024]; 42(34):[aprox. 3p.].Dsponible en: https://pubmed.ncbi.nlm.nih.gov/34458905/

https://doi.org/10.1093/eurheartj/ehab484

15. Shao H, Shi L, Lin Y, Fonseca V. Using modern risk engines and machine learning/artificial intelligence to predict diabetes complications: A focus on the BRAVO model. J Diabetes Complications [Internet]. 2022 [citado 18/01/2024]; 36(11): [aprox. 2p.]. Disponible en: https://pubmed.ncbi.nlm.nih.gov/36201893/

https://doi.org/10.1016/j.jdiacomp.2022.108316

16. Sorbye LM, Skjaerven R, Klungsoyr K, et al. Gestational diabetes mellitus and interpregnancy weight change: A population- based cohort study. PLoS Med [Internet]. 2017 [citado 18/01/2024]; 14(8):e1002367. Disponible en: https://pubmed.ncbi.nlm.nih.gov/28763446/

https://doi.org/10.1371/journal.pmed.1002367

17. Hageman S, Pennells L, Ojeda F, Kaptoge S, Kuulasmaa K, de Vries TE. SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe. Eur Heart J [Internet]. 2021 [citado 18/01/2024]; 42(25):[aprox. 2p.]. Disponible en: https://pubmed.ncbi.nlm.nih.gov/34120177/

https://doi.org/10.1093/eurheartj/ehab309

18. Instituto Cubano de Endocrinología. Guía cubana de práctica clínica basada en la evidencia. Diabetes mellitus tipo 2 [Internet]. La Habana Minsap; 2010 [citado 18/01/2024]. Disponible en: https://extranet.who.int/ncdccs/Data/CUB_D1_GUIA%20DE%20DIABETES%20CUBA%202013.pdf

19. Martín González IC, Plasencia Concepción D, González Pérez TL. Manual de Dietoterapia [Internet]. La Habana: Editorial Ciencias Médicas; 2001 [citado 18/01/2024]. Disponible en: https://www.bvscuba.sld.cu/libro/manual-de-dietoterapia/(PDF)

20. Orozco-Beltrána D, Mata-Casesb M, Artolac S, Conthed P, Mediavillae J, Mirandaf C. Abordaje de la adherencia en diabetes mellitus tipo2: situación actual y propuesta de posibles soluciones. Atención Primaria [Internet]. 2016 [citado 18/01/2024]; 48(6): [aprox. 3p.]. Disponible en: https://www.elsevier.es/es-revista-atencion-primaria-27-articulo-abordaje-adherencia-diabetes-mellitus-tipo2-S021265671500270X

https://doi.org/10.1016/j.aprim.2015.09.001

21. Fortea Altava M. Impacto de un Programa Educativo en el control de la Diabetes Mellitus Tipo 2 [Tesis]. Castellón: Universitat Jaume I [Internet]. 2017 [citado 18/01/2024]. Disponible en: https://www.tdx.cat/bitstream/handle/10803/442962/2017_Tesis_Fortea%20Altava_Milagros.pdf?sequence=1&isAllowed=y

22. Martínez Pina PP. Ayuno intermitente: Revisión bibliográfica sobre su efecto en la salud cardiometabólica y en la pérdida de peso [Tesis]. Catalunya: Universitat Oberta de Catalunya; 2019 [citado 18/01/2024]. Disponible en: https://openaccess.uoc.edu/webapps/o2/bitstream/10609/99577/6/pmartinezpinTFM0619memoria.pdf?_ga=2.181019438.86233045.1620026932-344894867.1612779061

23. Vasim I, Majeed CN, DeBoer MD. Intermittent Fasting and Metabolic Health. Nutrients [Internet]. 2022 [citado 18/01/2024]; 14(3): [aprox. 3p.]. Disponible en: https://pubmed.ncbi.nlm.nih.gov/35276989/

https://doi.org/10.3390/nu14030631

24. Canicoba M. Aplicaciones clínicas del ayuno intermitente. Rev Nutr Clin Metab [Internet]. 2020 [citado 18/01/2024]; 3(2): [aprox. 2p.]. Disponible en: https://dialnet.unirioja.es/servlet/articulo?codigo=9549697

https://doi.org/10.35454/rncm.v3n2.174

25. Davis CS, Clarke RE, Coulter SN, Rounsefell KN, Walker RE, Rauch CE, et al. Intermittent energy restriction and weight loss: a systematic review. Eur J Clin Nutr [Internet]; 2016 [citado 18/01/2024]; 70(3): [aprox. 3p.]. Disponible en: https://pubmed.ncbi.nlm.nih.gov/26603882/

https://doi.org/10.1038/ejcn.2015.195

26. Álvarez-Castro P, Sangiao-Alvarellos S, Brandón-Sandá I, Cordido F. Función endocrina en la obesidad. Endocrinol Nutr [Internet]. 2011 [citado 18/01/2024]; 58(8): [aprox. 2p.]. Disponible en: https://www.elsevier.es/es-revista-endocrinologia-nutricion-12-articulo-funcion-endocrina-obesidad-S1575092211002361

https://doi.org/10.1016/j.endonu.2011.05.015

27. Harvie M, Wright C, Pegington M, McMullan D, Mitchell E, Martin B. The effect of intermittent energy and carbohydrate restrictionv daily energy restriction on weight loss and metabolic disease risk markers in overweight women. Br J Nutr [Internet]. 2013 [citado 18/01/2024]; 110(8): [aprox. 2p.]. Disponible en: https://pubmed.ncbi.nlm.nih.gov/23591120/

https://doi.org/10.1017/s0007114513000792

28. Pincay-Chóez GC, Segura-Tabarez EI, Pionce-Parrales A. Ayuno intermitente y la resistencia a la insulina: Un análisis al valor predictivo Dominio de las Ciencias [Internet]. 2021 [citado 18/01/2024]; 7(2): [aprox. 2p.]. Disponible en: https://dialnet.unirioja.es/servlet/articulo?codigo=8385993

29. Huang G, Huang X, Wei G. Intermittent fasting for glycemic control in patients with type 2 diabetes: a meta-analysis of randomized controlled trials. Nutr Hosp [Internet]. 2025 [citado 18/01/2024]; 42(2):[aprox. 3p.]. Disponible en: https://pubmed.ncbi.nlm.nih.gov/40008664/

https://doi.org/10.20960/nh.05521

30. Joaquim L, Faria A, Loureiro H, Matafome P. Benefits, mechanisms, and risks of intermittent fasting in metabolic syndrome and type 2 diabetes. J Physiol Biochem [Internet]. 2022 [citado 18/01/2024]; 78(2): [aprox. 3p.]. Disponible en: https://pubmed.ncbi.nlm.nih.gov/34985730/

https://doi.org/10.1007/s13105-021-00839-4

Downloads

Published

2025-08-15

How to Cite

1.
Rivera Pérez T, Guevara de León T, Méndez Gálvez L, González Rodríguez A, Garrido Bosze I, Martínez Garcia D. Intermittent dietary restriction. Alternative treatment in type 2 diabetic patients. Acta Méd Centro [Internet]. 2025 Aug. 15 [cited 2026 Feb. 11];19(1):e2184. Available from: https://revactamedicacentro.sld.cu/index.php/amc/article/view/2184

Issue

Vol. 19 (2025): PUBLICACIÓN CONTINUA

Section

Original Articles

License

Copyright (c) 2025 Tania Rivera Pérez

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Authors who have publications with this journal agree to the following terms:

  1. Authors will retain their copyright and assign to the journal the right of first publication of their work, which will simultaneously be subject to a Creative Commons License / Attribution-Noncommercial 4.0 International (CC BY-NC 4.0) that allows third parties to share the work as long as its author and first publication in this journal are indicated.
  2. Authors may adopt other non-exclusive license agreements for distribution of the published version of the work (e.g., depositing it in an institutional repository or publishing it in a monographic volume) as long as the initial publication in this journal is indicated.
  3. Authors are allowed and encouraged to disseminate their work through the Internet (e.g., in institutional telematic archives or on their web page) before and during the submission process, which can produce interesting exchanges and increase citations of the published work. (See The effect of open access).